Last reviewed · How we verify

NCT07477717

COMBINATION OF LATISSIMUS DORSI AND GLUTEAL STRENGTHENING IN SACROILIAC DYSFUNCTION

Not yet recruiting NA Last updated 17 March 2026
What this trial tests

NA trial testing Gluteal strengthening exercise program in Sacroiliac Dysfunction in 40 participants. Not yet recruiting.

Timeline
1 April 2026
Primary endpoint
30 August 2026
30 November 2026

Quick facts

Lead sponsorCairo University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment40
Start date1 April 2026
Primary completion30 August 2026
Estimated completion30 November 2026
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 35 to 55, any sex, with Sacroiliac Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The current study will try to answer the following research question: In adults with sacroiliac joint dysfunction, what is the effect of combination LD strengthening exercises with gluteal strengthening exercises compared with gluteal strengthening exercises alone on the primary outcomes of this study (pain intensity during pressure on posterior superior iliac spine \[PSIS\] and neuropathic pain severity) and the secondary outcomes (disability, pelvic inclination, pelvic torsion, sacral inclination, GMax and LD strength)? Participants will be devided equally into two groups: 1. Group A (Control group): will receive a gluteal strengthening exercise program. 2. Group B (Intervention group): will receive the same gluteal strengthening exercise program as group A, in addition to the LD strengthening exercise program.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07477717.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing